Introduction
Influenza is an acute respiratory epidemic caused by influenza viruses and is characterized by high morbidity, rapid transmission and variability, which pose a serious threat to public health. Primary health-care institutions, as the net base of the health-care system, have an important role to play in the fight against influenza. The development of a combination of western and central medicine to treat influenza at the grass-roots level offers new ways to improve the effectiveness of influenza prevention and treatment, reduce medical costs and promote patient rehabilitation.
II. Advantages of a combination of Western and Central medicine to treat influenza
Multi-target mechanism
– Chinese medicine focuses on a holistic approach and on the issue of evidence, so as to improve the body ‘ s integrity and immunisation by regulating the balance of the body ‘ s yang and its aerobics. For example, some components of Chinese medicine can regulate the activity of immunocells and facilitate the production of antiviral substances such as jammers. At the same time, antiviral drugs such as Ostawe, which are used by Western doctors, can directly affect the influenza virus and inhibit its replication. Midwest medical combinations can play a role in the fight against influenza, both in terms of viruses and airframes.
2. Comprehensive symptoms improvement
– Influenza patients are often accompanied by a combination of heat, cough, ingesting and indigence. The western medicine has a relatively rapid effect in the areas of deheating, stinging and so forth, for example, in the case of abdominals such as Broven, which can rapidly reduce body temperature and alleviate symptoms such as headaches and muscle pains. The Chinese doctor ‘ s formulas, such as the dissipation of silver, have a unique advantage in improving respiratory symptoms such as cough and oscillation, as well as reducing overall body weakness, and can contribute to the overall amelioration and reduction of the patient ‘ s overall symptoms.
3. Reduction of complications and adverse effects
– The simple use of Western drug antivirals or treatment of symptoms may result in a number of adverse reactions, such as the risk of gastrointestinal discomfort in Ostave. The management of Chinese medicine can mitigate these adverse reactions to some extent, while reducing the risk of influenza causing complications such as pneumonia and myocarditis by increasing the body ‘ s resilience. For example, some of the Chinese pharmacological protruding agents help to protect important organs such as CPR and reduce the occurrence of complications.
III. The application of a combination of Western doctors in primary health-care institutions
1. Early exploration phase
– In the past, primary health-care institutions have been dominated by Western medicine, and with the gradual expansion of Chinese medicine at the grass-roots level, some experienced Chinese doctors have begun to try to apply Chinese medicine ‘ s methods of identification to flu patients. During this period, however, the combination of Chinese and western medicine was an individual empirical attempt, lacking systematic regulation and research support, and relying mainly on traditional Chinese medicine and simple Western medicine to treat the symptoms.
2. Progressive normative phase
– In recent years, with the emphasis placed by the State on the development of Chinese medicine, grass-roots medical institutions have begun to strengthen the normative construction of a combination of Chinese and Western medicine for the treatment of influenza. Relevant clinical guidelines and expert consensus have been developed, defining diagnostic criteria, treatment principles and common programmes for integration of western and central medicine. For example, the combination of Chinese and Chinese medicine with Western medicine is recommended on the basis of the patient ‘ s different types of evidence (e.g., rheumatism, pulmonary heat attack, etc.), and drug dosage, treatment, etc. has been regulated, improving the science and effectiveness of a combination of grass-roots and western medicine for the treatment of influenza.
IV. Current status of a combination of grass-roots and western medical care for influenza
1. Medical model
– Basic health facilities usually set up specialized heat clinics or influenza clinics during the flu season. The doctor first conducts detailed medical history inquiries, medical examinations and necessary laboratory examinations (e.g., antigens of influenza viruses) for a clear diagnosis. A combination of treatment programmes is then developed based on the patient ‘ s symptoms, signs and findings. In general, mild influenza patients are treated with oral Chinese or Chinese combinations of Western drugs, while in cases of greater severity, referral to higher-level hospitals or a combination of inpatient West and Central medicine is considered.
2. Drug availability and use
– With regard to the supply of medicines, primary health-care facilities are generally equipped with common anti-influenza drugs, such as Ostawe, Zanamwe and various Chinese preparations. e.g. pyrolysis of pyrolysis, pyrotechnic capsules, double yellow-coated oral fluids, etc. The doctor chooses the appropriate combination of drugs according to the patient ‘ s particular circumstances. For example, in cases of flu fever, which is visible in heat and ingest, silver stifling may be treated with a combination of Ostawe and co-opting with antithermal detoxifications such as double yellow-coated oral fluids.
3. Training and capacity-building of personnel
– In order to improve the integration of western and central medicine in the treatment of influenza, medical staff at the grass-roots level continue to enhance their training. Learning from the latest theories and techniques of combined flu treatment by Western and Central medicine, through participation in online academic lectures, training courses, etc. In some regions, appropriate technology promotion in Chinese medicine has been organized, which has been enriched by the use of acupuncture, push, etc., by primary doctors in the rehabilitation of influenza.
V. Challenges for a combination of grass-roots Western and Central medicine to treat influenza
1. Talent shortages
– The relative under-representation of medical professionals in primary health-care institutions, particularly in complex types of people who are both highly qualified in Chinese and western medicine. This has made it difficult for the Chinese and western doctors to accurately argue for the treatment of influenza and the rational choice of Western medicine, which affects the effectiveness of the treatment. Some grass-roots doctors do not fully understand Chinese medicine ‘ s classic theory and formula, and there are limitations in the application of Chinese medicine to treat influenza.
2. Quality and availability of drugs
– The quality of Chinese medicines is affected by a number of factors, such as the origin of the product, the harvest season, the artillery process, etc. Primary health-care institutions may face uneven quality of Chinese medicines when purchasing them, thus affecting the effectiveness of treatment. In addition, the supply of some Chinese preparations at the grass-roots level is sometimes not stable, especially during the high-prevalence flu season, and there may be a shortage of supplies, limiting the implementation of a combination medical treatment programme in West and Central China.
Health policy and reimbursement of costs
– The current health policy limits the scope and proportion of reimbursement for the combined treatment of influenza by Western and Central African doctors. Some Chinese medicine or Chinese medical treatment programmes are not covered by health insurance reimbursement, or have a low rate of reimbursement, which may place a high cost burden on patients when they undergo Chinese-Western medical treatment combined, to some extent affecting patients ‘ choice of treatment and the motivation of primary-level health-care institutions to undertake such treatment.
VI. Development prospects for a combination of Western medicine in primary health-care institutions
1. Scientific research and innovation
– In the future, more basic and clinical studies will be conducted on the combination of Chinese and Western medicine for the treatment of influenza as scientific inputs increase. An in-depth study of the mechanisms for the integration of Chinese and Western medicine and the screening of more effective Chinese and Western medicine combination treatment programmes. For example, the development of new types of Chinese drug antivirals or combinations of Western and Central medicine to provide stronger drug support for grass-roots treatment through modern biotechnology research on the role of pharmaceutical components in influenza viruses and their host cells.
2. Intelligence and information development
– Using the Internet, big data and artificial intelligence technology, primary health-care institutions can provide accurate advice on the smart diagnosis of influenza and a combination of treatment programmes for West and Central African medicine. Through the establishment of a clinical database of influenza patients, an artificial intelligence algorithm was used to analyse the patient ‘ s symptoms, signs, results of examinations, etc., to quickly and accurately identify and provide personalized advice on the combination of medical care in China and West. At the same time, the development of telemedicine technology will enable doctors at the grass-roots level to receive timely guidance from higher-level experts and raise the level of the combination of Western and Central medicine to treat influenza.
3. Policy support and institutional improvements
– The Government is expected to step up its support for the medical and pharmaceutical industry at the grass-roots level, optimizing the development of human resources, the supply of medicines and health policies. For example, the targeted development and continuing education of middle-level and middle-level medical personnel, the establishment of a stable Chinese drug supply security system, the adjustment of health-care reimbursement policies, the increase in the rate and scope of reimbursement for projects related to the combined treatment of influenza in West and Central China, and the promotion of a sustained and healthy development of the treatment of influenza in primary-level medical institutions.
Conclusion
The combination of treatment of influenza in primary health-care facilities has produced some positive results based on complementarities, gradually regulating and improving treatment models, drug use and training of personnel. However, many challenges remain, such as talent, medicines and health care. Looking to the future, as scientific innovation, intellectual development and policy support advance in many ways, it is hoped that the combination of grass-roots and western medicine for the treatment of influenza will lead to broader development prospects and play a greater role in safeguarding the health of people at the grass-roots level.
